Management tracks: Chan leaving FDA’s China office; plus Galera, Aridis and Palladio

Irene Chan has stepped down as deputy director of FDA's China office. She joined the office in 2009 as one of its first policy analysts, covering food safety. As deputy director, she worked closely with FDA’s Oncology Center of Excellence to develop a strategy for working with the agency’s counterparts in China on cancer product reviews to improve access to innovative therapies. An FDA newsletter announcing her departure did not reveal what’s next for Chan.

Galera Therapeutics Inc. said Christopher Degnan will join the cancer company as CFO, effective Oct. 21. Degnan was CFO at Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), where he is succeeded by A. Brian Davis...